US FDA makes it easier to switch naloxone

21 January 2019 - Deborah Wilkes


The US Food and Drug Administration (FDA) is making "unprecedented new efforts" to support the switch of naloxone from prescription to OTC status.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: